BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 22234513)

  • 1. N-terminal pro-brain natriuretic peptide could be a marker of subclinical atherosclerosis in patients with type 2 diabetes.
    Senmaru T; Fukui M; Tanaka M; Sakabe K; Ushigome E; Asano M; Yamazaki M; Hasegawa G; Nakamura N
    Heart Vessels; 2013 Mar; 28(2):151-6. PubMed ID: 22234513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-terminal fragment of probrain natriuretic peptide is associated with diabetes microvascular complications in type 2 diabetes.
    Hamano K; Nakadaira I; Suzuki J; Gonai M
    Vasc Health Risk Manag; 2014; 10():585-9. PubMed ID: 25328404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum cystatin C is associated with subclinical atherosclerosis in patients with type 2 diabetes: A retrospective study.
    Chung YK; Lee YJ; Kim KW; Cho RK; Chung SM; Moon JS; Yoon JS; Won KC; Lee HW
    Diab Vasc Dis Res; 2018 Jan; 15(1):24-30. PubMed ID: 29090609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum uric acid is related to cardiovascular events and correlates with N-terminal pro-B-type natriuretic peptide and albuminuria in patients with diabetes mellitus.
    Resl M; Clodi M; Neuhold S; Kromoser H; Riedl M; Vila G; Prager R; Pacher R; Strunk G; Luger A; Hülsmann M
    Diabet Med; 2012 Jun; 29(6):721-5. PubMed ID: 22050532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal fragment of pro-brain natriuretic peptide (NT-proBNP) for predicting silent myocardial ischaemia in type 2 diabetes mellitus independent of microalbuminuria.
    Hamano K; Abe M; Komi R; Kobayashi S
    Diabetes Metab Res Rev; 2010 Oct; 26(7):534-9. PubMed ID: 20812386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visit-to-visit variability in systolic blood pressure is correlated with diabetic nephropathy and atherosclerosis in patients with type 2 diabetes.
    Okada H; Fukui M; Tanaka M; Inada S; Mineoka Y; Nakanishi N; Senmaru T; Sakabe K; Ushigome E; Asano M; Yamazaki M; Hasegawa G; Nakamura N
    Atherosclerosis; 2012 Jan; 220(1):155-9. PubMed ID: 22100253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NT-proBNP levels, atherosclerosis and vascular function in asymptomatic type 2 diabetic patients with microalbuminuria: peripheral reactive hyperaemia index but not NT-proBNP is an independent predictor of coronary atherosclerosis.
    Reinhard H; Wiinberg N; Hansen PR; Kjær A; Petersen CL; Winther K; Parving HH; Rossing P; Jacobsen PK
    Cardiovasc Diabetol; 2011 Aug; 10():71. PubMed ID: 21812947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal pro-B-type natriuretic peptide: an independent marker for coronary artery disease in asymptomatic diabetic patients.
    Cosson E; Nguyen MT; Pham I; Pontet M; Nitenberg A; Valensi P
    Diabet Med; 2009 Sep; 26(9):872-9. PubMed ID: 19719707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [N-terminal pro-brain natriuretic peptide (NT-proBNP) and ischemia modified albumin (IMA) in exercise induced ischemia in patients with stable coronary artery disease].
    Piechota WN; Wierzbowski R; Piechota WT; Bejm J; Gielerak G
    Pol Arch Med Wewn; 2006 Jul; 116(1):640-7. PubMed ID: 17340970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NT-proBNP, echocardiographic abnormalities and subclinical coronary artery disease in high risk type 2 diabetic patients.
    Reinhard H; Hansen PR; Wiinberg N; Kjær A; Petersen CL; Winther K; Parving HH; Rossing P; Jacobsen PK
    Cardiovasc Diabetol; 2012 Mar; 11():19. PubMed ID: 22390472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal pro brain natriuretic peptide reflects long-term complications in type 1 diabetes.
    Grauslund J; Nybo M; Green A; Sjølie AK
    Scand J Clin Lab Invest; 2010 Oct; 70(6):392-8. PubMed ID: 20575653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-terminal Pro-B-type Natriuretic Peptide is Associated with Arterial Stiffness as Measured According to the Brachial-ankle Pulse Wave Velocity in Patients with Takayasu Arteritis.
    Liu Q; Dang AM; Chen BW; Lv NQ; Wang X; Zheng DY
    J Atheroscler Thromb; 2015; 22(6):628-36. PubMed ID: 25503292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma NT-proBNP is independently associated with albuminuria in type 2 diabetes.
    Zhou L; Cai X; Li M; Han X; Ji L
    J Diabetes Complications; 2016; 30(4):669-74. PubMed ID: 26922580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five-item version of the international index of erectile function correlated with albuminuria and subclinical atherosclerosis in men with type 2 diabetes.
    Fukui M; Tanaka M; Okada H; Iwase H; Mineoka Y; Senmaru T; Ohnishi M; Mogami S; Kitagawa Y; Yamazaki M; Hasegawa G; Nakamura N
    J Atheroscler Thromb; 2011; 18(11):991-7. PubMed ID: 21791882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cross sectional study comparing traditional risk factors with N-terminal pro-BNP in high risk groups for cardiovascular disease in Trinidad, West Indies.
    Shivananda Nayak B; Teelucksingh S; Jagessar A; Maharaj S; Maharaj N
    Diabetes Metab Syndr; 2013; 7(1):8-11. PubMed ID: 23517788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum N-terminal-pro-brain natriuretic peptide (NT-pro-BNP) and homocysteine levels in type 2 diabetic patients with asymptomatic left ventricular diastolic dysfunction.
    Görmüş U; Ozmen D; Ozmen B; Parildar Z; Ozdoğan O; Mutaf I; Bayindir O
    Diabetes Res Clin Pract; 2010 Jan; 87(1):51-6. PubMed ID: 19932518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Terminal Pro-Brain Type Natriuretic Peptide Predicts Cardiovascular Events Independently of Arterial Stiffness, Assessed By Carotid-to-Femoral Pulse Wave Velocity, in Apparently Healthy Subjects.
    Frary CE; Blicher MK; Olesen TB; Pareek M; Vishram-Nielsen JKK; Rasmussen S; Olsen MH
    Heart Lung Circ; 2024 Mar; 33(3):392-400. PubMed ID: 38290952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum N-terminal Pro-brain Natriuretic Peptide Level is Associated with the Development of Chronic Kidney Diseases in Patients with Type 2 Diabetes.
    Sawada R; Hashimoto Y; Senmaru T; Tanaka M; Ushigome E; Yamazaki M; Fukui M
    Endocr Metab Immune Disord Drug Targets; 2018; 18(6):590-595. PubMed ID: 29697035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of N-terminal Pro-B-type natriuretic peptide (NT-proBNP) in hemodialysis patients.
    Helal I; Belhadj R; Mohseni A; Bazdeh L; Drissa H; Elyounsi F; Abdallah TB; Abdelmoula J; Kheder A
    Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):262-8. PubMed ID: 20228511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of N-terminal Pro-brain Natriuretic Peptide and Myocardial Perfusion in Asymptomatic Adults (from the Multi-Ethnic Study of Atherosclerosis).
    Mitchell A; Misialek JR; Folsom AR; Duprez D; Alonso A; Jerosch-Herold M; Sanchez OA; Watson KE; Sallam T; Konety SH
    Am J Cardiol; 2015 May; 115(10):1341-5. PubMed ID: 25816778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.